Suchergebnisse - "Yoo, Changhoon"

PubPharm (328)

1

Clinical and Biomarker Analysis of a Phase I/II Study of PDR001 plus Imatinib for Advanced Treatment-refractory Gastrointestinal Stromal Tumors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Kim, H. | Ryu, M. | Park, Y. | +3

2

Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Rimini, M. | Stefanini, B. | Tada, T. | +75

3

Clinical outcomes of second-line therapy following disease progression on first-line modified FOLFIRINOX for borderline resectable and locally advanced pancreatic adenocarcinoma

enthalten in: ResearchSquare.com | 2024

von Yoon, H. | Shin, Y. | Ryoo, B. | +17

4

Recent Advances in Systemic Therapy for Advanced Intrahepatic Cholangiocarcinoma

enthalten in: Liver cancer | 2024

von Yoo, C. | Hyung, J. | Chan, S.

5

Clinical outcomes of second-line therapy following disease progression on first-line modified FOLFIRINOX for borderline resectable and locally advanced pancreatic adenocarcinoma

enthalten in: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al. | 2024

von Yoon, H. | Shin, Y. | Ryoo, B. | +17

6

Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment

enthalten in: Journal of hepatology | 2024

von Chan, S. | Ryoo, B. | Mo, F. | +7

7

Metabolic tumor burden as a prognostic indicator after neoadjuvant chemotherapy in pancreatic cancer

enthalten in: International journal of surgery (London, England) | 2024

von Lee, W. | Oh, M. | Kim, J. | +16

8

Regorafenib plus nivolumab in unresectable hepatocellular carcinoma : the phase 2 RENOBATE trial

enthalten in: Nature medicine | 2024

von Kim, H. | Jung, S. | Lim, H. | +16

9

Differential T-cell and monocyte responses in hepatocellular carcinoma treated with regorafenib plus nivolumab: an integrated clinical and biomarker analysis of the phase 2 RENOBATE trial

enthalten in: ResearchSquare.com | 2024

von Yoo, C. | Kim, H. | Jung, S. | +12

10

Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors

enthalten in: Scientific reports | 2024

von Kim, J. | Kim, J. | Kim, Y. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[33]